Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients

Journal of Clinical Oncology

Volumn 14, Issue 4, 1996, Pages 1122-1127

  Yamaguchi, A ^a   Urano, T ^a   Goi, T ^a   Saito, M ^a   Takeuchi, K ^a   Hirose, K ^a   Nakagawara, G ^a   Shiku, H ^a   Furukawa, K ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HERMES ANTIGEN; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; COLON MUCOSA; COLORECTAL CANCER; EXON; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029868519     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.4.1122     Document Type: Article

References (21)

1. Jalkanen S, Steere AC, Fox RI, et al: A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. Science 233:556-558, 1986
2. Carter WG, Wayner EA: Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J Biol Chem 263:4193-4201, 1988
3. Lesley J, Schulte R, Hyman R: Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. Exp Cell Res 187:224-233, 1990
4. Aruffo A, Stamenkovic I, Melnick M, et al: CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303-1313, 1990
5. Miyake K, Underhill CB, Lesley J, et al: Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med 172:69-75, 1990
6. Hofmann M, Rudy W, Zöller M, et al: CD44 splice variants confer metastatic behavior in rats: Homologous sequences are expressed in human tumor cell lines. Cancer Res 51:5292-5297, 1991
7. Günthert U, Hofmann M, Rudy W, et al: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24, 1991
8. Screaton GR, Bell MV, Jackson DG, et al: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89:12160-12164, 1992
9. Jackson DG, Buckley J, Bell JI: Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 267:4732-4739, 1992
10. Rudy W, Hofmann M, Schwartz-Albiez R, et al: The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from diferent splice variants: Each one individually suffices to confer metastatic behavior. Cancer Res 53:1262-1268, 1993
11. Lesley J, Hyman R, Kincade PW: CD44 and its interaction with extracellular matrix. Adv Immunol 54:271-335, 1993
12. Matsumura Y, Tarin D: Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340:1053-1058, 1992
13. Tanabe KK, Ellis LM, Saya H: Expression of CD44R1 adhesion molecule in colon carcinomas and metastases. Lancet 341:725-726, 1993
14. Takeuchi K, Yamaguchi A, Urano T, et al: Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis. Jpn J Cancer Res 86:292-297, 1995
15. American Joint Committee on Cancer: Manual for Staging of Cancer (ed 4). Philadelphia, PA, Lippincott, 1992, pp 75-79
16. Japanese Research Society for Cancer of the Colon and Rectum: General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Jpn J Surg 13:557-573, 1983
17. Seiter BS, Arch R, Reber S, et al: Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med 177:443-455, 1993
18. Arch R, Wirth K, Hofmann M, et al: Participation in normal immune response of a metastasis-inducing splice variant of CD44. Science 257:682-685, 1992
19. Guo Y-J, Liu G, Wang X, et al: Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res 54:422-426, 1994
20. Wielenga VJM, Heider K-H, Offerhaus GJA, et al: Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53:4754-4756, 1993
21. Mayer B, Jauch KW, Günthert U, et al: De-novo expression of CD44 and survival in gastric cancer. Lancet 342:1019-1022, 1993